Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
22 current organizations shown on this profile
Board positions
22 supported by public sources, 0 supplied by the profile owner
Committee roles
5Roles supported by the sources cited on this profile
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

Ms. McKenzie has corporate leadership experience and industry knowledge from her service as an executive and innovator in biotechnology and technology industries. She is a proven technology leader with extensive digital, technology, and cybersecurity knowledge based on nearly three decades of experience, including roles at Workday and Amgen.

Sources are shown with the information they support.

Current roles

Appointments & responsibilities

Board appointments

Governance

Board appointments, committee responsibilities and disclosed relationships.

Committee appointments across companies

Structured records are unavailable. This does not establish that no records exist.

Board and advisory record

Board service

Sources are shown with each role, education record, or credential.

Director

agilon health, inc.

2023-01-01 · current

Confirmed by public sourceView source

Director

Vertex Pharmaceuticals

2020-01-01 · current

Confirmed by public sourceView source

Connections

Explore the roles, education and affiliations published in this record.

agilon health, inc.

Open agilon health, inc. profile →

Director at agilon health, inc.

2023-01-01 → End not stated

current · source reported

Observed: 2026-09-24

agilon health, inc.agilon health, inc.Vertex Pharmaceuti…Vertex PharmaceuticalsDiana McKenzie

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec Filingagilon health, inc. director board sourceSupports Board membership, Committee assignments, Director since, Board independence.Open sourceSource 2 · Sec FilingVRTX DEF 14A director slateSupports AI and ML experience, Board role, Committee assignments, Cybersecurity experience, Technology background.Open sourceSource 3 · Sec FilingVertex Pharmaceuticals Incorporated director board sourceSupports Board membership, Director since, Board independence.Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:diana-mckenzie
Record version
public-0

Published evidence records

8 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. agilon health, inc. director board source

    sec filing · Source published: Apr 22, 2026 · Retrieved: May 3, 2026

    Supports 4 claims
    • Board independence: Independent director · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of agilon health, inc. · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of Vertex Pharmaceuticals Incorporated · Claim reviewed: May 3, 2026
    • Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 3, 2026

  2. AGL DEF 14A director slate

    sec filing · Source published: Apr 22, 2026 · Retrieved: Apr 24, 2026

    Supports 2 claims
    • Board role: Board role: Director · Claim reviewed: May 16, 2026
    • Committee assignments: Committee assignments: Audit, Compensation, Compliance and Quality · Claim reviewed: Apr 24, 2026

  3. Open source

    sec proxy · Source published: Apr 22, 2026 · Retrieved: Apr 24, 2026

    Supports 1 claim
    • Professional Role: Director at agilon health, inc. · Claim reviewed: May 16, 2026

  4. VRTX DEF 14A director slate

    sec filing · Source published: Apr 2, 2026 · Retrieved: May 16, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Board role: Board role: Director · Claim reviewed: May 16, 2026
    • Committee assignments: Committee assignments: Audit and Finance, Management Development and Compensation · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience reported in filings · Claim reviewed: May 16, 2026
    • Technology background: Technology background reported in filings · Claim reviewed: May 16, 2026

  5. Vertex Pharmaceuticals Incorporated director board source

    sec filing · Source published: Apr 3, 2025 · Retrieved: May 3, 2026

    Supports 3 claims
    • Board independence: Independent director · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of agilon health, inc. · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of Vertex Pharmaceuticals Incorporated · Claim reviewed: May 3, 2026

  6. Open source

    sec filing · Source published: Jan 1, 2020 · Retrieved: May 3, 2026

    Supports 1 claim
    • Professional Role: Director at Vertex Pharmaceuticals · Claim reviewed: May 16, 2026

  7. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of agilon health, inc. · Claim reviewed: May 3, 2026

  8. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Vertex Pharmaceuticals Incorporated · Claim reviewed: May 3, 2026

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

AI and ML experience · Source reportedAI and ML experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Board independence · CorroboratedIndependent directorSupported by 2 public records2 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Board membership · CorroboratedServes on the board of agilon health, inc.Supported by 4 public records3 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board membership · CorroboratedServes on the board of Vertex Pharmaceuticals IncorporatedSupported by 4 public records3 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board role · CorroboratedBoard role: DirectorSupported by 2 public records2 sources
Verification
Corroborated
Confidence
92%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed Apr 24, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Committee assignments · Source reportedNo committee assignment disclosed in the cited filing1 source
Verification
Source reported
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Committee assignments · Source reportedCommittee assignments: Audit and Finance, Management Development and Compensation1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Committee assignments · Source reportedCommittee assignments: Audit, Compensation, Compliance and Quality1 source
Verification
Source reported
Confidence
88%
Last reviewed
Apr 24, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed Apr 24, 2026

Cybersecurity experience · Source reportedCybersecurity experience reported in filings1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Technology background · Source reportedTechnology background reported in filings1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

View all sources8 records
  1. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: Board membership · Committee assignments · Director since · Board independence

  2. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed Apr 24, 2026

    Supports: Board role · Committee assignments

  3. https://www.sec.gov/Archives/edgar/data/1831097/000162828026026544/agl-20260422.htm

    Sec Proxy · Tier not stated · Reviewed Apr 24, 2026

    Supports: Director at agilon health, inc. (NYSE: AGL)

  4. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: AI and ML experience · Board role · Committee assignments · Cybersecurity experience · Technology background

  5. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: Board membership · Director since · Board independence

  6. https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm

    Sec Filing · Tier not stated · Reviewed May 3, 2026

    Supports: Director at Vertex Pharmaceuticals (NASDAQ: VRTX)

  7. https://www.sec.gov/Archives/edgar/data/1831097/000162828026026544/agl-20260422.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership

  8. https://www.sec.gov/Archives/edgar/data/0000875320/000087532025000160/vrtx-20250403.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership